On January 26, 2023, RepliCel Life Sciences Inc. closed the transaction. The transaction included participation from two investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +4.99% | -.--% | -4.89% |
May. 17 | RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-4.89% | 2.78M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-4.40% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- REPCF Stock
- News RepliCel Life Sciences Inc.
- RepliCel Life Sciences Inc. announced that it has received CAD 0.116419 million in funding